Mylan NV
MYL
Delayed Nasdaq - 11/21 10:00:00 pm
37.23USD
+2%
Prev.36.5000
Open36.1700
High37.4900
Low36.1700
Volume8 026 949
Last news
Financials
Sales 2017 12 010 M
EBIT 2017 3 407 M
R. net 2017 1 265 M
Debt 2017 13 664 M
Rend. 2017 -
P/E ratio 2017 15,01
P/E ratio 2018 10,55
EV / Sales 2017 2,80x
EV / Sales 2018 2,48x
Capitalization 19 966 M
Company
Mylan N.V., is a pharmaceutical company which engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products.The company was founded on July 7, 2014 and is headquartered in Hatfield, United Kingdom.
Sector :
Pharmaceuticals - NEC
Calendar :
2018-02-28 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance39,040,145,2
Spread/Res.-4,6%-7,1%-18%
Spread/Supp.5,3%26%22%
Support35,329,630,5